Future studies with large cohorts of patients screened for circulating AFP expression and bioactivity will need to be performed, as previous experience emphasizes that not all mitochondrial diseases induce GDF15 and FGF21 expression (11), further arguing that there is specificity in the systemic response to mitochondrial dysfunction. The gene discussed is AFP; the disease is inborn mitochondrial metabolism disorder.